Rennova Health Inc (RNVA)

[dade]

On December 22, 2016,held its Annual Meeting of Stockholders approved the following proposals:

(i) to elect five directors, each to hold office until the Company's next Annual Meeting of Stockholders or until their successors are duly elected and qualified;

(ii) to ratify the appointment of Green & Company, CPAs as our independent registered public accounting firm for the fiscal year ending December 31, 2016;

(iii) to approve an amendment to our Certificate of Incorporation to effect a reverse split of all of the outstanding shares of our common stock at a specific ratio within a range
from 1-for-10 to 1-for-30,
and to grant authorization to the Board of Directors to determine,
in its discretion,
the specific ratio and timing of the reverse split any time before

December 31, 2017,

subject to the Board of Directors’ discretion to abandon such amendment; (iv) to approve an advisory (non-binding) resolution on the Company’s executive compensation; and (v) to transact such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.

http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=11754459&RcvdDate=12/28/2016&CoName=RENNOVA%20HEALTH%2C%20INC.&FormType=8-K&View=html